The largest database of trusted experimental protocols

Sirt1 sirna

Manufactured by Sangon
Sourced in China

SIRT1-siRNA is a small interfering RNA (siRNA) designed to target and silence the expression of the SIRT1 gene. SIRT1 is a protein-coding gene that plays a role in various cellular processes, including metabolism, stress response, and aging. The SIRT1-siRNA product is intended for use in research applications to study the function and regulation of the SIRT1 gene.

Automatically generated - may contain errors

4 protocols using sirt1 sirna

1

Silencing SIRT1 in HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To silence SIRT1, HepG2 cells were transfected with siRNA against human SIRT1 (33–100 nM) using Lipofectamine 2000 according to the manufacturer’s guidelines. The siRNA sequence was synthesized by Sangon Biotech (Shanghai, China) (SIRT1 siRNA: sense, 5′-UAGGUGCCCAGCUGAUGAAUU-3′, anti-sense, 5′-UUCAUCAGCUGGGCACCUAUU-3′; negative control siRNA: sense, 5′-UUCUCCGAACGUGUCACGUUU-3′, anti-sense, 5′-ACGUGACACGUUCGGAGAAUU-3′).The shRNA sequence (SIRT1 shRNA, 5′-GATCCTAGGTGCCCAGCTGATGAGTTCAAGAGACTCATCAGCTGGGCACCTATTTTTG-3′ or control shRNA, 5′-GATCCTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTTCGGAGAATTTTTG-3′) was synthesized by Sangon Biotech and inserted into the pGreenPuro vector (SBI). Recombinant lentiviruses encoding mouse SIRT1 shRNA (LV-shSIRT1) or negative control shRNA (LV-shCtrl) were treated as described previously34 (link).
+ Open protocol
+ Expand
2

Sirt1 and Nrf2 Knockdown in Glomerular Mesangial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The specific siRNA sequences, including Sirt1-siRNA, Nrf2-siRNA and the negative control, were synthesized by Sangon Biotech (Shanghai, China). The sequences of Sirt1-siRNA were as follows: sense: 5′-CCAGUAGCACUAAUUCCAATT-3′, antisense: 5′-UUGGAAUUAGUGCUACUGGTT-3′. The sequences of Nrf2-siRNA were as below: sense: 5′-GAGGAUGGGAAACCUUACUTT-3′, antisense: 5′-AGUAAGGUUUCCCAUCCUCTT-3′. Appropriate siRNA was transiently transfected into GMCs with lipofectamine® RNAiMAX (Invitrogen, United States). After 48 h incubation, the transfection medium was replaced with fresh serum-free DMEM for another 12 h. After various treatments, the cells were harvested for WB.
+ Open protocol
+ Expand
3

Knockdown of SIRT1 in KGN Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SIRT1-siRNA was designed and synthesized by Sangon Biotech. The SIRT1-siRNA sequences were as follows
Forward: 5’-GCGGGAAUCCAAAGGAUAAUUTT-3’.
Reverse: 5’-AAUUAUCCUUUGGAUUCCCGCTT-3’
Control-siRNA
Forward: 5’-UUCUCCGAACGUGUCACGUTT-3’
Reverse: 5’-ACGUGACACGUUCGGAGAATT-3’.
KGN cells were cultured in a 6-well plate until they reached 70-80% confluence. Then, siRNA, serum-free culture medium, and transfection reagent Lipo8000™ were diluted in the appropriate proportions. The siRNA mixture was added to the cells in the 6-well plate. The cells were transfected for two days, and then SIRT1 protein expression was assessed.
+ Open protocol
+ Expand
4

miR-126 Modulation and SIRT1 Silencing

Check if the same lab product or an alternative is used in the 5 most similar protocols
miR-126 mimics (cat. no. miR10000444-1-5; 5′-UCGUACCGUGAGUAAUAAUGCG-3′) and miR-negative control (miR-NC; cat. no. miR1N0000002-1-5; 5′-UUCUCCGAACGUGUCACGUTT-3′) were synthesized by Guangzhou RiboBio Co, Ltd. SIRT1-small interfering RNA (SIRT1-siRNA; forward, 5′-ACUUUGCUGUAACCCUGUA-3′ and reverse, 5′-UACAGGGUUACAGCAAAGU-3′) or negative control siRNA sequence (Con-siRNA; 5′-CUAGCUUAUGUGGACCUCG-3′) were synthesized by Sangon Biotech Co., Ltd. Transfection of miR-126 mimics, miR-NC, SIRT1-siRNA or Con-siRNA at a final concentration of 50 nM were performed using Lipofectamine® 3000 (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer's protocols. At 48 h after transfection, transfection efficiency was determined by reverse transcription-quantitative PCR (RT-qPCR) or western blotting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!